Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 6, 2026
Sale
Shares
1,560
Price
$1.95
Total Value
$3.04K
Shares Held After
18,033
% of Holdings
8.0%
Mar 6, 2026
Sale
Shares
40
Price
$437.65
Total Value
$17.51K
Shares Held After
12,490
% of Holdings
0.3%
Mar 6, 2026
Sale
Shares
80
Price
$436.69
Total Value
$34.94K
Shares Held After
12,530
% of Holdings
0.6%
Mar 6, 2026
Sale
Shares
80
Price
$435.31
Total Value
$34.83K
Shares Held After
12,610
% of Holdings
0.6%
Mar 6, 2026
Sale
Shares
160
Price
$434.20
Total Value
$69.47K
Shares Held After
12,690
% of Holdings
1.2%
Mar 6, 2026
Sale
Shares
116
Price
$432.56
Total Value
$50.18K
Shares Held After
12,850
% of Holdings
0.9%
Mar 6, 2026
Sale
Shares
120
Price
$430.90
Total Value
$51.71K
Shares Held After
12,966
% of Holdings
0.9%
Mar 6, 2026
Sale
Shares
40
Price
$429.58
Total Value
$17.18K
Shares Held After
13,086
% of Holdings
0.3%
Mar 6, 2026
Sale
Shares
160
Price
$429.00
Total Value
$68.64K
Shares Held After
13,126
% of Holdings
1.2%
Mar 6, 2026
Sale
Shares
80
Price
$427.85
Total Value
$34.23K
Shares Held After
13,286
% of Holdings
0.6%
Mar 6, 2026
Sale
Shares
420
Price
$426.86
Total Value
$179.28K
Shares Held After
13,366
% of Holdings
3.0%
Mar 6, 2026
Sale
Shares
40
Price
$425.08
Total Value
$17.00K
Shares Held After
13,786
% of Holdings
0.3%
Mar 6, 2026
Sale
Shares
646
Price
$431.94
Total Value
$279.03K
Shares Held After
13,826
% of Holdings
4.5%
Mar 6, 2026
Sale
Shares
3,817
Price
$18.75
Total Value
$71.57K
Shares Held After
339,392
% of Holdings
1.1%
Mar 6, 2026
Sale
Shares
1,663
Price
$431.94
Total Value
$718.32K
Shares Held After
161,829
% of Holdings
1.0%

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Huntsman Carole — Chief Commercial Officer
Mar 6, 2026
Sale
Shares
419
Price
$431.94
Total Value
$180.98K
Shares Held After
12,692
% of Holdings
3.2%
Mar 6, 2026
Sale
Shares
360
Price
$431.94
Total Value
$155.50K
Shares Held After
12,138
% of Holdings
2.9%
Mar 6, 2026
Sale
Shares
491
Price
$431.94
Total Value
$212.08K
Shares Held After
452,213
% of Holdings
0.1%
Mar 6, 2026
Sale
Shares
608
Price
$12.84
Total Value
$7.81K
Shares Held After
34,804
% of Holdings
1.7%
Mar 5, 2026
Sale
Shares
4,000
Price
$75.56
Total Value
$302.24K
Shares Held After
185,543
% of Holdings
2.1%
Mar 5, 2026
Sale
Shares
3,312
Price
$75.42
Total Value
$249.79K
Shares Held After
189,543
% of Holdings
1.7%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Mar 5, 2026
Sale
Shares
11,000
Price
$61.88
Total Value
$680.68K
Shares Held After
50,440
% of Holdings
17.9%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Mar 5, 2026
Sale
Shares
15,000
Price
$61.87
Total Value
$928.05K
Shares Held After
61,440
% of Holdings
19.6%

INSMED Inc (INSM)

Lewis William — Director
Mar 5, 2026
Sale
Shares
2,128
Price
$147.54
Total Value
$313.97K
Shares Held After
301,185
% of Holdings
0.7%

INSMED Inc (INSM)

Lewis William — Director
Mar 5, 2026
Sale
Shares
3,899
Price
$146.66
Total Value
$571.83K
Shares Held After
303,313
% of Holdings
1.3%

INSMED Inc (INSM)

Lewis William — Director
Mar 5, 2026
Sale
Shares
2,589
Price
$145.27
Total Value
$376.10K
Shares Held After
307,212
% of Holdings
0.8%

INSMED Inc (INSM)

Lewis William — Director
Mar 5, 2026
Sale
Shares
2,083
Price
$144.23
Total Value
$300.43K
Shares Held After
309,801
% of Holdings
0.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
200
Price
$487.65
Total Value
$97.53K
Shares Held After
36,844
% of Holdings
0.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
743
Price
$486.52
Total Value
$361.48K
Shares Held After
37,044
% of Holdings
2.0%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
1,006
Price
$485.32
Total Value
$488.24K
Shares Held After
37,787
% of Holdings
2.6%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
1,398
Price
$484.55
Total Value
$677.40K
Shares Held After
38,793
% of Holdings
3.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
1,086
Price
$483.54
Total Value
$525.12K
Shares Held After
40,191
% of Holdings
2.6%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
1,177
Price
$482.68
Total Value
$568.11K
Shares Held After
41,277
% of Holdings
2.8%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
720
Price
$481.33
Total Value
$346.56K
Shares Held After
42,454
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
1,602
Price
$480.22
Total Value
$769.31K
Shares Held After
43,174
% of Holdings
3.6%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 5, 2026
Sale
Shares
368
Price
$479.43
Total Value
$176.43K
Shares Held After
44,776
% of Holdings
0.8%

Orthofix Medical Inc. (OFIX)

McPherron Aviva — Pres, Global Ops & Qual
Mar 5, 2026
Sale
Shares
1,263
Price
$12.55
Total Value
$15.85K
Shares Held After
67,853
% of Holdings
1.8%

QUEST DIAGNOSTICS INC (DGX)

PREVOZNIK MICHAEL E — SVP & General Counsel
Mar 5, 2026
Sale
Shares
3,878
Price
$206.21
Total Value
$799.68K
Shares Held After
37,557
% of Holdings
9.4%

Zai Lab Ltd (ZLAB)

Du Ying — Director
Mar 5, 2026
Sale
Shares
50,000
Price
$19.22
Total Value
$961.05K
Shares Held After
964,161
% of Holdings
4.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 5, 2026
Sale
Shares
153
Price
$326.24
Total Value
$49.91K
Shares Held After
20,569
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 5, 2026
Sale
Shares
148
Price
$324.60
Total Value
$48.04K
Shares Held After
20,722
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 5, 2026
Sale
Shares
233
Price
$323.25
Total Value
$75.32K
Shares Held After
20,870
% of Holdings
1.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Mar 5, 2026
Sale
Shares
124
Price
$321.81
Total Value
$39.90K
Shares Held After
21,103
% of Holdings
0.6%
Mar 5, 2026
Sale
Shares
482,149
Price
$3.71
Total Value
$1.79M
Shares Held After
8,030,899
% of Holdings
5.7%

Schrödinger, Inc. (SDGR)

Tran Yvonne — EVP, CLO & CPO
Mar 5, 2026
Sale
Shares
1,094
Price
$12.89
Total Value
$14.11K
Shares Held After
52,683
% of Holdings
2.0%

Orthofix Medical Inc. (OFIX)

REINHARDT MAX — President, Global Spine
Mar 5, 2026
Sale
Shares
1,053
Price
$12.55
Total Value
$13.22K
Shares Held After
25,348
% of Holdings
4.0%
Mar 5, 2026
Purchase
Shares
10,000
Price
$3.90
Total Value
$39.00K
Shares Held After
402,702
% of Holdings
2.5%

Schrödinger, Inc. (SDGR)

Akinsanya Karen — President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Mar 5, 2026
Sale
Shares
1,366
Price
$12.90
Total Value
$17.63K
Shares Held After
69,956
% of Holdings
1.9%
Mar 5, 2026
Sale
Shares
2,363
Price
$12.55
Total Value
$29.66K
Shares Held After
88,746
% of Holdings
2.6%

QUEST DIAGNOSTICS INC (DGX)

Doherty Catherine T. — EVP, Regional Businesses
Mar 5, 2026
Sale
Shares
5,558
Price
$206.21
Total Value
$1.15M
Shares Held After
67,122
% of Holdings
7.6%
Version: v26.3.29